By Beck Mahoney
In 2009, Patricia Jones walked into Hudson Valley Brain and Spine, a well-known neurosurgical group, for a “routine” surgery– a decision that would change her life. The 56-year-old payroll manager from Rockland County reported tingling in her arms, hands, and neck, and chose to seek care from the respected medical group. During the procedure to relieve her pain, a bone fragment was lodged in the spinal cord’s protective covering, resulting in a cord contusion. However, doctors failed to properly assess the injury and proceeded with the operation. The result: Jones left as a quadraplegic. "On August 18th, Patricia Jones walked into Good Samaritan Hospital," Jones’ lawyer told the jury during her medical malpractice suit. "What she didn't know is that those would be the last steps that she would ever take."
Jones’ case is all too common. In the United States alone, up to 40% of initial spine surgeries result in Failed Back Surgery Syndrome (FBSS), a symptom of medical negligence or error before, during, or after operation. One major cause for failed back surgery is incorrect diagnosis. While surgeons have different ways to determine the cause of your back pain, many rely on clinical observation alone, leaving room for potential oversight. Surgeon error is also a main factor in causing a failed back surgery. Despite rigorous training, surgeons are still prone to making mistakes, and in Jones’ case, the consequences were catastrophic. Post-operation complications are not uncommon, with nearly 10% of patients experiencing nerve damage or infection, according to the National Institutes of Health.
A flawless operation might guarantee physical relief, but it can still lead to heavy financial burdens. Without proper medical insurance, the spinal surgery itself can reach six-figure costs, burying patients in medical debt. Indirect costs only compound the issue, as lengthy hospital stays, revisions, and infection treatments can cost patients tens of thousands of dollars.
Even so, the outlook for spinal surgery is increasingly promising with the rise of artificial intelligence. Advancing technology not only improves the safety of spine surgery and lowers complication rates, but can also lessen the financial burden.
For example, artificial intelligence is making surgeries safer by assisting clinicians end-to-end. Before surgery, AI helps clinicians interpret signs, symptoms, and test results to refine diagnosis and forecast patient-specific outcomes. During and after surgery, it guides decisions and supports postoperative care to optimize recovery. Machine learning, a branch of artificial intelligence, can analyze patient data to guide clinicians with evidence-based treatment options, further supporting clinicians throughout the surgery process. Guna Kalanjiyam, a researcher at Meenakshi Mission Hospital in India, writes, “spine surgeries have their set of risks and complications, and the information and assistance provided by AI could help surgeons avoid minor to catastrophic adverse events in patient care.” Taken together, artificial intelligence and machine learning deliver a safer, more personalized surgical journey, from pre-op planning through intraoperative guidance to post-op follow-up, reducing complications and improving patient outcomes.
Moreover, artificial intelligence is helping reduce indirect costs associated with spinal surgery. A study conducted by Louisiana State University Health Sciences Center’s Department of Neurology found significant data showing the cost-effectiveness of integrating artificial intelligence into spine surgery treatment across 557 surgeries. In their study, they cited that across all the surgeries, “time savings averaged 3.4 minutes per 1-level MIS procedure with robotic technology, resulting in savings of $5,713.” They also found that improved screw placement accuracy resulted in “9.47 revisions being avoided, with cost savings of $314,661,” and that more accurate surgeries resulted in “140 fewer total hospital admission days ($251,860) and avoided 2.3 infections ($36,312)”. In total, the use of artificial intelligence produced an estimated savings of $608,546 across 557 spinal cases, an average of over $1,000 per case.
For investors, the integration of artificial intelligence presents a significant opportunity. According to a report by Future Market Insights, the AI-powered spinal surgery market is currently valued at 1.11 billion dollars and is slated to reach 2.46 billion by 2035, implying a compound annual growth rate of 8.3%. The predicted steady growth over the next ten years is driven by increasing demand for precision surgical technologies and growing adoption of artificial intelligence systems that will provide enhanced patient outcomes. The leading competitor in this market is Alphatec Holdings, a San Diego based medical technology company. Alphatec Holdings leads the market with a 21.7% market share, gaining a competitive edge by offering comprehensive AI surgical solutions and advanced navigation systems with a focus on premium and hospital applications. Market consolidation trends indicate that larger medical device companies, such as Alphatec Holdings, will acquire specialty AI surgery developers to broaden their portfolios and gain access to specific algorithmic capabilities.
Some individuals express concern that consolidation will lead to higher surgery costs for consumers and reduced innovation, as large companies will face less market competition. Already in 2024, the Federal Trade Commission blocked medical device producer Edwards Lifescience's proposed acquisition of JenaValve Technology, citing that the deal “threatens to reduce competition in the market, likely resulting in reduced innovation, diminished product quality, and potentially increased prices for consumers, according to the complaint.”
However, an Alphatec Holding employee ensured that their company is committed to protecting consumers and maintaining their reputation as an industry leader in innovation. In an interview, the anonymous employee stated, “our company stands by our mission to revolutionize the approach to spine surgery.” They assured that consumers have “nothing to worry about” as the company is “focused on patient care above all else.” If Alphatec Holdings delivers on this vision, patients can look forward to safer procedures, faster recoveries, and more accessible care.
Patricia Jones’ story underscores the devastating consequences that can arise when spinal surgeries go wrong, whether due to diagnostic oversight, surgical error, or postoperative complications. The integration of artificial intelligence into spinal surgery offers a promising solution, delivering increased precision, fewer complications, and meaningful cost savings for both providers and patients. As companies like Alphatec Holdings lead the charge in AI-driven innovation, the spine surgery industry stands on the brink of a transformative era. While market consolidation raises valid concerns about cost and competition, prioritizing patient care and responsible innovation can ensure that this technology benefits those who need it most. If deployed thoughtfully, AI has the potential not only to prevent tragedies but also to redefine the future of spinal health.